Semler Scientific Stock (NASDAQ:SMLR)

Semler Scientific, Inc. develops and delivers cutting-edge technology solutions aimed at boosting the clinical effectiveness and operational efficiency of medical professionals throughout the United States. A flagship offering from the company is QuantaFlo, a rapid, four-minute diagnostic test performed in-office to assess blood flow. This tool allows healthcare providers to incorporate crucial blood flow measurements into their comprehensive evaluations of a patient's vascular health. Their clientele is diverse, spanning various medical specialties such as cardiology, internal medicine, nephrology, endocrinology, podiatry, and family practice. Beyond individual practitioners, Semler Scientific also serves significant healthcare organizations, including insurance plans, integrated care delivery networks, independent physician groups, and other entities that engage with the healthcare sector, such as risk assessment firms. The company distributes its products via a combination of its own sales team and a network of authorized distributors. Founded in 2007, Semler Scientific, Inc. is based in Santa Clara, California.